Aquatic Capital Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$449K Sell
55,138
-43,211
-44% -$392K 0.01% 786
2025
Q4
$661K Buy
+98,349
New +$741K 0.02% 665
2022
Q3
Sell
-7,900
Closed -$406K 1439
2022
Q2
$406K Buy
+7,900
New +$409K 0.13% 197

Other funds holding NVAX

Aquatic Capital Management's NVAX Position: Q1 2026 in Review

Aquatic Capital Management reduced its Novavax (NVAX) stake by 44% in Q1 2026, selling an estimated $392K and leaving 55,138 shares worth $449K. The position accounts for 0.01% of the portfolio, ranked #786.

Aquatic Capital Management first reported a position in NVAX in Q2 2022 and has held it in 3 quarters since. The position peaked at $661K in Q4 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Aquatic Capital Management held 55,138 shares of Novavax worth $449K as of Q1 2026.
  • Aquatic Capital Management sold 43,211 Novavax shares in Q1 2026, an estimated $392K.
  • Novavax made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #786 holding.
  • Aquatic Capital Management first reported a position in Novavax in Q2 2022 and has held it in 3 quarters since.
  • Aquatic Capital Management's Novavax position peaked at $661K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.